 | • レポートコード：QYR2104Z1417 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、CNS治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（神経変性疾患、気分障害、統合失調症、自閉症、うつ病）、用途別市場規模（病院用、クリニック用、家庭用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・CNS治療の市場動向 ・企業の競争状況、市場シェア ・CNS治療の種類別市場規模（神経変性疾患、気分障害、統合失調症、自閉症、うつ病） ・CNS治療の用途別市場規模（病院用、クリニック用、家庭用、その他） ・CNS治療の北米市場規模2016-2027（アメリカ、カナダ） ・CNS治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・CNS治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・CNS治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・CNS治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Janssen Pharmaceuticals、Allergan、Lundbeck、Teva、Camber Pharmaceuticals、Zhejiang Haisen Pharmaceutical、Jewim Pharmaceutical、Cipla、Merck Sharp & Dohme Corp.、Eli Lilly、GlaxoSmithKline、Novartis、LUPIN、ZYDUS PHARMS、Biogen、Otsuka Pharmaceutical、Astra Zeneca、Takeda） ・結論 |
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).
Mental health segment accounted for the largest market share in 2016. It is expected to retain its dominance over the forecast period owing to developing therapeutic options for mental diseases such as personality disorders and binge eating disorders. This segment is followed by degenerative disorders segment. There is growing awareness regarding neurodegenerative diseases owing to increase in initiatives by government and nongovernment organizations, such as Alzheimer’s and Related Disorders Society of India. These organizations conduct awareness campaigns and conferences, such as Asia Pacific Conference of ADI at New Delhi and Kerala State Initiative on Dementia, which encourage the adoption of treatment for degenerative and mental disorders.
Market Analysis and Insights: Global CNS Therapeutics Market
The global CNS Therapeutics market size is projected to reach US$ 106190 million by 2026, from US$ 76300 million in 2019, at a CAGR of 4.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CNS Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CNS Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CNS Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CNS Therapeutics market.
Global CNS Therapeutics Scope and Market Size
CNS Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CNS Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Neurodegenerative Diseases
Mood Disorders
Schizophrenia
Autism
Depression
Segment by Application
Hospital Use
Clinic Use
Household
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Janssen Pharmaceuticals
Allergan
Lundbeck
Teva
Camber Pharmaceuticals
Zhejiang Haisen Pharmaceutical
Jewim Pharmaceutical
Cipla
Lundbeck
Teva
GlaxoSmithKline
Novartis
LUPIN
ZYDUS PHARMS
Biogen
Otsuka Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CNS Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Neurodegenerative Diseases
1.2.3 Mood Disorders
1.2.4 Schizophrenia
1.2.5 Autism
1.2.6 Depression
1.3 Market by Application
1.3.1 Global CNS Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CNS Therapeutics Market Perspective (2016-2027)
2.2 CNS Therapeutics Growth Trends by Regions
2.2.1 CNS Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CNS Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 CNS Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 CNS Therapeutics Industry Dynamic
2.3.1 CNS Therapeutics Market Trends
2.3.2 CNS Therapeutics Market Drivers
2.3.3 CNS Therapeutics Market Challenges
2.3.4 CNS Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CNS Therapeutics Players by Revenue
3.1.1 Global Top CNS Therapeutics Players by Revenue (2016-2021)
3.1.2 Global CNS Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global CNS Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CNS Therapeutics Revenue
3.4 Global CNS Therapeutics Market Concentration Ratio
3.4.1 Global CNS Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CNS Therapeutics Revenue in 2020
3.5 CNS Therapeutics Key Players Head office and Area Served
3.6 Key Players CNS Therapeutics Product Solution and Service
3.7 Date of Enter into CNS Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CNS Therapeutics Breakdown Data by Type
4.1 Global CNS Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global CNS Therapeutics Forecasted Market Size by Type (2022-2027)
5 CNS Therapeutics Breakdown Data by Application
5.1 Global CNS Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global CNS Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America CNS Therapeutics Market Size (2016-2027)
6.2 North America CNS Therapeutics Market Size by Type
6.2.1 North America CNS Therapeutics Market Size by Type (2016-2021)
6.2.2 North America CNS Therapeutics Market Size by Type (2022-2027)
6.2.3 North America CNS Therapeutics Market Size by Type (2016-2027)
6.3 North America CNS Therapeutics Market Size by Application
6.3.1 North America CNS Therapeutics Market Size by Application (2016-2021)
6.3.2 North America CNS Therapeutics Market Size by Application (2022-2027)
6.3.3 North America CNS Therapeutics Market Size by Application (2016-2027)
6.4 North America CNS Therapeutics Market Size by Country
6.4.1 North America CNS Therapeutics Market Size by Country (2016-2021)
6.4.2 North America CNS Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe CNS Therapeutics Market Size (2016-2027)
7.2 Europe CNS Therapeutics Market Size by Type
7.2.1 Europe CNS Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe CNS Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe CNS Therapeutics Market Size by Type (2016-2027)
7.3 Europe CNS Therapeutics Market Size by Application
7.3.1 Europe CNS Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe CNS Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe CNS Therapeutics Market Size by Application (2016-2027)
7.4 Europe CNS Therapeutics Market Size by Country
7.4.1 Europe CNS Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe CNS Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific CNS Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific CNS Therapeutics Market Size by Type
8.2.1 Asia-Pacific CNS Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CNS Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CNS Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific CNS Therapeutics Market Size by Application
8.3.1 Asia-Pacific CNS Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CNS Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CNS Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific CNS Therapeutics Market Size by Region
8.4.1 Asia-Pacific CNS Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CNS Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America CNS Therapeutics Market Size (2016-2027)
9.2 Latin America CNS Therapeutics Market Size by Type
9.2.1 Latin America CNS Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America CNS Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America CNS Therapeutics Market Size by Type (2016-2027)
9.3 Latin America CNS Therapeutics Market Size by Application
9.3.1 Latin America CNS Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America CNS Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America CNS Therapeutics Market Size by Application (2016-2027)
9.4 Latin America CNS Therapeutics Market Size by Country
9.4.1 Latin America CNS Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America CNS Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CNS Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa CNS Therapeutics Market Size by Type
10.2.1 Middle East & Africa CNS Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CNS Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CNS Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa CNS Therapeutics Market Size by Application
10.3.1 Middle East & Africa CNS Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CNS Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CNS Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa CNS Therapeutics Market Size by Country
10.4.1 Middle East & Africa CNS Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CNS Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer CNS Therapeutics Introduction
11.1.4 Pfizer Revenue in CNS Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Company Details
11.2.2 Janssen Pharmaceuticals Business Overview
11.2.3 Janssen Pharmaceuticals CNS Therapeutics Introduction
11.2.4 Janssen Pharmaceuticals Revenue in CNS Therapeutics Business (2016-2021)
11.2.5 Janssen Pharmaceuticals Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan CNS Therapeutics Introduction
11.3.4 Allergan Revenue in CNS Therapeutics Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Lundbeck
11.4.1 Lundbeck Company Details
11.4.2 Lundbeck Business Overview
11.4.3 Lundbeck CNS Therapeutics Introduction
11.4.4 Lundbeck Revenue in CNS Therapeutics Business (2016-2021)
11.4.5 Lundbeck Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva CNS Therapeutics Introduction
11.5.4 Teva Revenue in CNS Therapeutics Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Camber Pharmaceuticals
11.6.1 Camber Pharmaceuticals Company Details
11.6.2 Camber Pharmaceuticals Business Overview
11.6.3 Camber Pharmaceuticals CNS Therapeutics Introduction
11.6.4 Camber Pharmaceuticals Revenue in CNS Therapeutics Business (2016-2021)
11.6.5 Camber Pharmaceuticals Recent Development
11.7 Zhejiang Haisen Pharmaceutical
11.7.1 Zhejiang Haisen Pharmaceutical Company Details
11.7.2 Zhejiang Haisen Pharmaceutical Business Overview
11.7.3 Zhejiang Haisen Pharmaceutical CNS Therapeutics Introduction
11.7.4 Zhejiang Haisen Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021)
11.7.5 Zhejiang Haisen Pharmaceutical Recent Development
11.8 Jewim Pharmaceutical
11.8.1 Jewim Pharmaceutical Company Details
11.8.2 Jewim Pharmaceutical Business Overview
11.8.3 Jewim Pharmaceutical CNS Therapeutics Introduction
11.8.4 Jewim Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021)
11.8.5 Jewim Pharmaceutical Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla CNS Therapeutics Introduction
11.9.4 Cipla Revenue in CNS Therapeutics Business (2016-2021)
11.9.5 Cipla Recent Development
11.10 Merck Sharp & Dohme Corp.
11.10.1 Merck Sharp & Dohme Corp. Company Details
11.10.2 Merck Sharp & Dohme Corp. Business Overview
11.10.3 Merck Sharp & Dohme Corp. CNS Therapeutics Introduction
11.10.4 Merck Sharp & Dohme Corp. Revenue in CNS Therapeutics Business (2016-2021)
11.10.5 Merck Sharp & Dohme Corp. Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly CNS Therapeutics Introduction
11.11.4 Eli Lilly Revenue in CNS Therapeutics Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline CNS Therapeutics Introduction
11.12.4 GlaxoSmithKline Revenue in CNS Therapeutics Business (2016-2021)
11.12.5 GlaxoSmithKline Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis CNS Therapeutics Introduction
11.13.4 Novartis Revenue in CNS Therapeutics Business (2016-2021)
11.13.5 Novartis Recent Development
11.14 LUPIN
11.14.1 LUPIN Company Details
11.14.2 LUPIN Business Overview
11.14.3 LUPIN CNS Therapeutics Introduction
11.14.4 LUPIN Revenue in CNS Therapeutics Business (2016-2021)
11.14.5 LUPIN Recent Development
11.15 ZYDUS PHARMS
11.15.1 ZYDUS PHARMS Company Details
11.15.2 ZYDUS PHARMS Business Overview
11.15.3 ZYDUS PHARMS CNS Therapeutics Introduction
11.15.4 ZYDUS PHARMS Revenue in CNS Therapeutics Business (2016-2021)
11.15.5 ZYDUS PHARMS Recent Development
11.16 Biogen
11.16.1 Biogen Company Details
11.16.2 Biogen Business Overview
11.16.3 Biogen CNS Therapeutics Introduction
11.16.4 Biogen Revenue in CNS Therapeutics Business (2016-2021)
11.16.5 Biogen Recent Development
11.17 Otsuka Pharmaceutical
11.17.1 Otsuka Pharmaceutical Company Details
11.17.2 Otsuka Pharmaceutical Business Overview
11.17.3 Otsuka Pharmaceutical CNS Therapeutics Introduction
11.17.4 Otsuka Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021)
11.17.5 Otsuka Pharmaceutical Recent Development
11.18 Astra Zeneca
11.18.1 Astra Zeneca Company Details
11.18.2 Astra Zeneca Business Overview
11.18.3 Astra Zeneca CNS Therapeutics Introduction
11.18.4 Astra Zeneca Revenue in CNS Therapeutics Business (2016-2021)
11.18.5 Astra Zeneca Recent Development
11.18 Takeda
.1 Takeda Company Details
.2 Takeda Business Overview
.3 Takeda CNS Therapeutics Introduction
.4 Takeda Revenue in CNS Therapeutics Business (2016-2021)
.5 Takeda Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global CNS Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Neurodegenerative Diseases
Table 3. Key Players of Mood Disorders
Table 4. Key Players of Schizophrenia
Table 5. Key Players of Autism
Table 6. Key Players of Depression
Table 7. Global CNS Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global CNS Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global CNS Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global CNS Therapeutics Market Share by Regions (2016-2021)
Table 11. Global CNS Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global CNS Therapeutics Market Share by Regions (2022-2027)
Table 13. CNS Therapeutics Market Trends
Table 14. CNS Therapeutics Market Drivers
Table 15. CNS Therapeutics Market Challenges
Table 16. CNS Therapeutics Market Restraints
Table 17. Global CNS Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global CNS Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top CNS Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CNS Therapeutics as of 2020)
Table 20. Ranking of Global Top CNS Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by CNS Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players CNS Therapeutics Product Solution and Service
Table 24. Date of Enter into CNS Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global CNS Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global CNS Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global CNS Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global CNS Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global CNS Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global CNS Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global CNS Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global CNS Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America CNS Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America CNS Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America CNS Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America CNS Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe CNS Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe CNS Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe CNS Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe CNS Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific CNS Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific CNS Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific CNS Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific CNS Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America CNS Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America CNS Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America CNS Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America CNS Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa CNS Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa CNS Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa CNS Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa CNS Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer CNS Therapeutics Product
Table 67. Pfizer Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Janssen Pharmaceuticals Company Details
Table 70. Janssen Pharmaceuticals Business Overview
Table 71. Janssen Pharmaceuticals CNS Therapeutics Product
Table 72. Janssen Pharmaceuticals Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Janssen Pharmaceuticals Recent Development
Table 74. Allergan Company Details
Table 75. Allergan Business Overview
Table 76. Allergan CNS Therapeutics Product
Table 77. Allergan Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Allergan Recent Development
Table 79. Lundbeck Company Details
Table 80. Lundbeck Business Overview
Table 81. Lundbeck CNS Therapeutics Product
Table 82. Lundbeck Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Lundbeck Recent Development
Table 84. Teva Company Details
Table 85. Teva Business Overview
Table 86. Teva CNS Therapeutics Product
Table 87. Teva Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Teva Recent Development
Table 89. Camber Pharmaceuticals Company Details
Table 90. Camber Pharmaceuticals Business Overview
Table 91. Camber Pharmaceuticals CNS Therapeutics Product
Table 92. Camber Pharmaceuticals Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Camber Pharmaceuticals Recent Development
Table 94. Zhejiang Haisen Pharmaceutical Company Details
Table 95. Zhejiang Haisen Pharmaceutical Business Overview
Table 96. Zhejiang Haisen Pharmaceutical CNS Therapeutics Product
Table 97. Zhejiang Haisen Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Zhejiang Haisen Pharmaceutical Recent Development
Table 99. Jewim Pharmaceutical Company Details
Table 100. Jewim Pharmaceutical Business Overview
Table 101. Jewim Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Jewim Pharmaceutical Recent Development
Table 103. Cipla Company Details
Table 104. Cipla Business Overview
Table 105. Cipla CNS Therapeutics Product
Table 106. Cipla Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Cipla Recent Development
Table 108. Merck Sharp & Dohme Corp. Company Details
Table 109. Merck Sharp & Dohme Corp. Business Overview
Table 110. Merck Sharp & Dohme Corp. CNS Therapeutics Product
Table 111. Merck Sharp & Dohme Corp. Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Merck Sharp & Dohme Corp. Recent Development
Table 113. Eli Lilly Company Details
Table 114. Eli Lilly Business Overview
Table 115. Eli Lilly CNS Therapeutics Product
Table 116. Eli Lilly Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Eli Lilly Recent Development
Table 118. GlaxoSmithKline Company Details
Table 119. GlaxoSmithKline Business Overview
Table 120. GlaxoSmithKline CNS Therapeutics Product
Table 121. GlaxoSmithKline Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 122. GlaxoSmithKline Recent Development
Table 123. Novartis Company Details
Table 124. Novartis Business Overview
Table 125. Novartis CNS Therapeutics Product
Table 126. Novartis Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 127. Novartis Recent Development
Table 128. LUPIN Company Details
Table 129. LUPIN Business Overview
Table 130. LUPIN CNS Therapeutics Product
Table 131. LUPIN Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 132. LUPIN Recent Development
Table 133. ZYDUS PHARMS Company Details
Table 134. ZYDUS PHARMS Business Overview
Table 135. ZYDUS PHARMS CNS Therapeutics Product
Table 136. ZYDUS PHARMS Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 137. ZYDUS PHARMS Recent Development
Table 138. Biogen Company Details
Table 139. Biogen Business Overview
Table 140. Biogen CNS Therapeutics Product
Table 141. Biogen Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 142. Biogen Recent Development
Table 143. Otsuka Pharmaceutical Company Details
Table 144. Otsuka Pharmaceutical Business Overview
Table 145. Otsuka Pharmaceutical CNS Therapeutics Product
Table 146. Otsuka Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 147. Otsuka Pharmaceutical Recent Development
Table 148. Astra Zeneca Company Details
Table 149. Astra Zeneca Business Overview
Table 150. Astra Zeneca CNS Therapeutics Product
Table 151. Astra Zeneca Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 152. Astra Zeneca Recent Development
Table 153. Takeda Company Details
Table 154. Takeda Business Overview
Table 155. Takeda CNS Therapeutics Product
Table 156. Takeda Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million)
Table 157. Takeda Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CNS Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Neurodegenerative Diseases Features
Figure 3. Mood Disorders Features
Figure 4. Schizophrenia Features
Figure 5. Autism Features
Figure 6. Depression Features
Figure 7. Global CNS Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Use Case Studies
Figure 9. Clinic Use Case Studies
Figure 10. Household Case Studies
Figure 11. Other Case Studies
Figure 12. CNS Therapeutics Report Years Considered
Figure 13. Global CNS Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global CNS Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global CNS Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global CNS Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global CNS Therapeutics Market Share by Players in 2020
Figure 18. Global Top CNS Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CNS Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by CNS Therapeutics Revenue in 2020
Figure 20. Global CNS Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global CNS Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America CNS Therapeutics Market Share by Type (2016-2027)
Figure 24. North America CNS Therapeutics Market Share by Application (2016-2027)
Figure 25. North America CNS Therapeutics Market Share by Country (2016-2027)
Figure 26. United States CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe CNS Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe CNS Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe CNS Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific CNS Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific CNS Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific CNS Therapeutics Market Share by Region (2016-2027)
Figure 42. China CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America CNS Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America CNS Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America CNS Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa CNS Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa CNS Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa CNS Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 62. Janssen Pharmaceuticals Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 64. Lundbeck Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 65. Teva Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 66. Camber Pharmaceuticals Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 67. Zhejiang Haisen Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 68. Jewim Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 69. Cipla Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 70. Merck Sharp & Dohme Corp. Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 71. Eli Lilly Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 72. GlaxoSmithKline Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 73. Novartis Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 74. LUPIN Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 75. ZYDUS PHARMS Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 76. Biogen Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 77. Otsuka Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 78. Astra Zeneca Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 79. Takeda Revenue Growth Rate in CNS Therapeutics Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の中枢神経系（CNS）障害治療市場規模・現状・予測（2021年-2027年） Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics Market Analysis and Insights: Global Central Nervous System Disorders …- 世界の自閉症スペクトラム障害（ASD）診断・治療市場規模・現状・予測（2021年-2027年） Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Over the past few years, with the increased number of infants an…
- 世界の統合失調症治療薬市場規模・現状・予測（2021年-2027年） Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition. The second-generation antipsychotic drugs segment accounted for the majority market shares because these d…
- 世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 世界の感染性疾患治療市場規模・現状・予測（2021年-2027年） In this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites Market Analysis and Insights: Global Communicable Diseases Therapeutics Market The global Communicable Diseases Therapeutics market siz…